Deutsche Bank Cuts Amedisys (AMED) to Sell Following Q3 Miss
Deutsche Bank downgraded Amedisys (NASDAQ: AMED) from Hold to Sell with a price target of $8.00 (from $11.00). Analyst Darren ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)